| Mar 6 2014 |
Health Care Update - March 4, 2014 |
Mintz |
| Mar 6 2014 |
The Copaxone Story in the U.S. and India |
Michael Best & Friedrich LLP |
| Mar 6 2014 |
Avoid the Anti-Corruption “Blacklist:” Chinese Agency Guidance |
Mintz |
| Mar 5 2014 |
Subjective or Objective Truth? Supreme Court to Decide What Is an “Untrue” Statement of Opinion |
Mintz |
| Mar 5 2014 |
Notes On Increasing Acute and Post-Acute Integration |
Sheppard, Mullin, Richter & Hampton LLP |
| Mar 5 2014 |
Will Your Lockout/Tagout (LOTO) Program Stand Up to An Occupational Safety and Health Administration (OSHA) Inspection? - Part 3 |
Jackson Lewis P.C. |
| Mar 5 2014 |
The Department of Justice Continues to Bring the "Heat" in Pursuing Health Care Fraud |
Barnes & Thornburg LLP |
| Mar 5 2014 |
Keeping Current – Recent Changes in Employment Laws |
von Briesen & Roper, s.c. |
| Mar 5 2014 |
The Largest Stark Settlement (So Far) is Pending in the Halifax Health Case |
von Briesen & Roper, s.c. |
| Mar 5 2014 |
Food & Drug Administration (FDA) Releases Draft Guidance on Distribution of Scientific and Medical Publications on Unapproved Uses |
Barnes & Thornburg LLP |
| Mar 4 2014 |
Supplier of Industrial and Medical Gases is Acquired |
McBrayer, McGinnis, Leslie and Kirkland, PLLC |
| Mar 4 2014 |
The Affordable Care Act—Countdown to Compliance for Employers, Week 43: Coordinating the 3-Month Delay under Employer Shared Responsibility Rules with the Ban on Waiting Periods Longer than 90 Days |
Mintz |
| Mar 4 2014 |
Departments of Labor, Treasury, and Health and Human Services Issue Final and Proposed Regulations Implementing the 90-day Limit on Waiting Periods under the Affordable Care Act |
Mintz |
| Mar 4 2014 |
The Tipping Point? Consolidation of Medical Practices is Good for Patients … Until it’s Not |
Greenberg Traurig, LLP |
| Mar 4 2014 |
Health Care Reform Update: Government Releases 90-Day Waiting Restriction Final Rules and a Proposal |
Jackson Lewis P.C. |
| Mar 3 2014 |
New York Council Amends Earned Sick Time Act Yet Again; Employers Must Comply by April 1, 2014 |
Mintz |
| Mar 3 2014 |
GlaxoSmithKline v. Banner Pharmacaps – Written Description Requirement 101 |
Schwegman, Lundberg & Woessner, P.A. |
| Mar 2 2014 |
Will Your LOTO (Lockout/Tagout) Program Stand Up to an OSHA (Occupational Safety and Health Administration) Inspection? - Part 2 |
Jackson Lewis P.C. |
| Mar 2 2014 |
Novel IRS Guidance on HRAs (Health Reimbursement Arrangements), VEBAs (Voluntary Employees’ Beneficiary Association) and Domestic Partner Benefits |
Katten |
| Mar 2 2014 |
Bill To Drug Test Pharma Employees Filed In U.S. House of Representatives |
Jackson Lewis P.C. |
| Feb 28 2014 |
Will Your Lockout/Tagout (LOTO) Program Stand Up to an Occupational Safety and Health Administration (OSHA) Inspection? - Part 1 |
Jackson Lewis P.C. |
| Feb 28 2014 |
New York City Council Expands New York Earned Sick Time Act |
Jackson Lewis P.C. |
| Feb 27 2014 |
Food and Drug Administration (FDA) Announces Start of Voluntary Supply Chain Pilot Program |
Faegre Drinker |
| Feb 27 2014 |
D.C. Lawsuit Challenges Health Exchange Distinctions |
Giordano, Halleran & Ciesla, P.C. |
| Feb 27 2014 |
2014 Work Plan for Skilled Nursing Facilities (SNFs), Hospice & Home Health Services |
McBrayer, McGinnis, Leslie and Kirkland, PLLC |
| Feb 27 2014 |
Consumer Class Actions Trending From Attacking ‘All Natural’ to ‘Raw’ |
Greenberg Traurig, LLP |
| Feb 27 2014 |
Can a Consumer Products Company Moot Class Actions by Offering a Refund? |
Greenberg Traurig, LLP |
| Feb 27 2014 |
Portland Sick Leave – Five Traps |
Jackson Lewis P.C. |
| Feb 27 2014 |
Feds’ Argument in Favor of Premium Tax Credit Gains Momentum, Still Under Attack in Federal Courts |
McDermott Will & Emery |
| Feb 27 2014 |
Newark, New Jersey Enacts Paid Sick Leave Ordinance |
Jackson Lewis P.C. |
| Feb 26 2014 |
Endo Health Solutions & Endo Pharmaceuticals to Pay $192.7 Million in Qui Tam Case Alleging Off-Label Marketing Of Lidoderm Pain Treatment Patches |
Tycko & Zavareei LLP |
| Feb 26 2014 |
Unprecedented HIPAA Fine May Mean Increased Scrutiny and Penalties Re: Health Insurance Portability and Accountability Act |
Mintz |
| Feb 26 2014 |
FDA (Food and Drug Administration) Releases Final Guidance on “Dear Doctor” Letters That Omits Controversial Behavior Modification Assessment Provision |
McDermott Will & Emery |
| Feb 26 2014 |
HHS (Department of Health and Human Services) to Conduct Survey About Which HIPAA (Health Insurance Portability and Accountability Act) Covered Entities and Business Associates Should Be Audited |
Jackson Lewis P.C. |
| Feb 25 2014 |
Food and Drug Administration (FDA) Releases Final Guidance on Medical Device Pre-Submission Program |
Barnes & Thornburg LLP |
